Cargando…

Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center

Detalles Bibliográficos
Autores principales:	Ozaki, Yukinori, Masuda, Jun, Kataoka, Akemi, Oikado, Katsunori, Uehiro, Natsue, Inagaki, Lina, Kato, Chieko, Morizono, Hidetomo, Takano, Toshimi, Ueno, Takayuki, Ohno, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833718/ https://www.ncbi.nlm.nih.gov/pubmed/33340450 http://dx.doi.org/10.1016/j.ccell.2020.12.004

Ejemplares similares

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study
por: Ozaki, Yukinori, et al.
Publicado: (2022)

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer
por: Inagaki, Lina, et al.
Publicado: (2021)

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer
por: Inoue, Yuka, et al.
Publicado: (2022)

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study
por: Ozaki, Yukinori, et al.
Publicado: (2022)

Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report
por: Maeshima, Yurina, et al.
Publicado: (2021)

Assessment of a cancer genomic profile test for patients with metastatic breast cancer
por: Fukada, Ippei, et al.
Publicado: (2022)

Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study
por: Ueno, Takayuki, et al.
Publicado: (2019)

Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin
por: Saeki, Sumito, et al.
Publicado: (2023)

Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan
por: Baba, Tomohisa, et al.
Publicado: (2023)

A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy
por: Abe, Tomomi, et al.
Publicado: (2017)

Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities
por: Izumori, Ayumi, et al.
Publicado: (2019)

Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan
por: Miyashita, Mika, et al.
Publicado: (2015)

Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
por: Uehiro, Natsue, et al.
Publicado: (2016)

Effectiveness of self-help workbook intervention on quality of life in cancer patients receiving chemotherapy: results of a randomized controlled trial
por: Takano, Toshimi, et al.
Publicado: (2021)

Preoperative Screening CT and PET/CT Scanning for Acral Melanoma: Is it Necessary?
por: Ide, Taketoshi, et al.
Publicado: (2021)

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
por: Ozaki, Yukinori, et al.
Publicado: (2017)

Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
por: Ozaki, Yukinori, et al.
Publicado: (2018)

Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report
por: Aoki, Yoichi, et al.
Publicado: (2023)

Data of programmed death-ligand 1 expression and VEGF: Nivolumab, bevacizumab and paclitaxel For HER2-negative metastatic breast cancer
por: Ozaki, Yukinori, et al.
Publicado: (2022)

Clonazepam-associated Bradycardia in a Disabled Elderly Woman with Multiple Complications
por: Maruyoshi, Hidetomo, et al.
Publicado: (2017)

Ewing sarcoma of the liver with multilocular cystic mass formation: a case report
por: Ozaki, Yukinori, et al.
Publicado: (2015)

Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study
por: Ozaki, Yukinori, et al.
Publicado: (2018)

Label‐free multiphoton excitation imaging as a promising diagnostic tool for breast cancer
por: Matsui, Takahiro, et al.
Publicado: (2022)

Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients
por: Makita, Masujiro, et al.
Publicado: (2015)

Curative resection for locally advanced sigmoid colon cancer using neoadjuvant chemotherapy with FOLFOX plus panitumumab: A case report
por: Tomizawa, Kenji, et al.
Publicado: (2017)

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study
por: Yamashiro, Hiroyasu, et al.
Publicado: (2018)

Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review
por: Takahashi, Momoko, et al.
Publicado: (2019)

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01
por: Yamashiro, Hiroyasu, et al.
Publicado: (2020)

Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS)
por: Yamamoto, Yutaka, et al.
Publicado: (2022)

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
por: Masuda, Norikazu, et al.
Publicado: (2020)

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
por: Yamashita, Toshinari, et al.
Publicado: (2020)

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
por: Yamashita, Toshinari, et al.
Publicado: (2020)

Multiple Omics Uncovers Host–Gut Microbial Mutualism During Prebiotic Fructooligosaccharide Supplementation
por: Kato, Tamotsu, et al.
Publicado: (2014)

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
por: Ishiguro, Hiroshi, et al.
Publicado: (2020)

Evaluating the usefulness of breast strain elastography for intraductal lesions
por: Kokubu, Yumi, et al.
Publicado: (2021)

Preoperative staging of perforated diverticulitis by computed tomography scanning
por: Gielens, M. P. M., et al.
Publicado: (2012)

Accurate Preoperative Diagnosis of Ovarian Pregnancy with Transvaginal Scan
por: Gupta, Natasha, et al.
Publicado: (2012)

Prognostic Stratification According to Size and Dominance of Radiologic Solid Component in Clinical Stage IA Lung Adenocarcinoma
por: Nakao, Masayuki, et al.
Publicado: (2022)

Localized Pigmented Villonodular Synovitis of the Bilateral Knee: A Case Report
por: Okamura, Hiroki, et al.
Publicado: (2022)

Medial Meniscus Posterior Root Reconstruction and Open- Wedge High Tibial Osteotomy for Medial Meniscus Posterior Root Tear with Varus Knee: A Case Report
por: Ohno, Takuya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nhkt06vjqarnhqtfu07gjbutgc